OrbusNeich Medical noted that it has identified unlicensed use by Boston Scientific of certain technologies protected under US Patent No 7,682,384 B2.

As the owner by assignment of all right, title, and interest in the ‘Stent with Helical Elements,’ OrbusNeich believes that its previously announced infringement claims against Boston Scientific in the US District Court for the District of Massachusetts, specifically related to the Boston Scientific Liberte and Taxus Liberte branded stents, could be expanded to include the newly granted patent.

Accordingly, OrbusNeich Medical has filed with the Ccourt a motion to amend its existing complaint against Boston Scientific.

Al Novak, president and CEO of OrbusNeich Medical, said: “OrbusNeich is pleased to have been awarded this valuable patent, which further recognizes the innovativeness of the company in stent design.

“We are committed to taking all appropriate actions to ensure that our proprietary technology and extensive research and development efforts are to the benefit of OrbusNeich’s investors, employees and physician customers and their patients – not those of competitors.”